Chin. J. Org. Chem. ›› 2013, Vol. 33 ›› Issue (03): 634-639.DOI: 10.6023/cjoc201211015 Previous Articles     Next Articles

Notes

β2-AR激动剂BI-167107的合成

王江波a, Seungkirl Ahnb, Alem W.Kahsaib, 刘蓉c, 任杰a, 胡昆a, 孙小强c, 陈新a   

  1. a 常州大学制药与生命科学学院 常州 213164;
    b Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA;
    c 常州大学石油化工学院 常州 213164
  • 收稿日期:2012-11-18 修回日期:2012-12-06 发布日期:2012-12-20
  • 通讯作者: 孙小强, 陈新 E-mail:xinchen@cczu.edu.cn; xqsun@jpu.edu.cn
  • 基金资助:

    国家自然科学基金(Nos. 21272029, 81272982)资助项目.

Synthesis of β2-AR Agonist BI-167107

Wang Jiangboa, Ahn Seungkirlb, Kahsai Alem W.b, Liu Rongc, Ren Jiea, Hu Kuna, Sun Xiaoqiangc, Chen Xina   

  1. a School of Pharmaceutical and Life Science, Changzhou University, Changzhou 213164;
    b Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA;
    c School of Petrochemical Engineering, Changzhou University, Changzhou 213164
  • Received:2012-11-18 Revised:2012-12-06 Published:2012-12-20
  • Supported by:

    Project supported by the National Natural Science Foundation of China (Nos. 21272029, 81272982).

BI-167107 is a new long-acting β2-adrenergic receptor (β2-AR) agonist, and has important application in determining the critical structures of receptor/ligand proteins complex of G-protein-coupled receptor (GPCR). By employing 2-nitroresorcinol as starting material, a practical synthetic route for BI-167107 has been developed, involving 7-step reactions. The structure of the target molecule has been confirmed by 1H NMR, 13C NMR and MS techniques. The advantages of the synthetic route include avoiding use of toxic reagents and being suitable for scale up preparation of BI-167107 and other benzoxazine derivatives.

Key words: BI-167107, β2-adrenergic receptors, agonists, GPCR, benzoxazine, synthesis